{
    "code": "56027535",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56027535",
    "time": "2020-03-27 06:14:10",
    "許可證字號": "衛部醫器輸字第027535號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD7455",
    "有效日期": "114\/07\/28",
    "發證日期": "104\/07\/28",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602753500",
    "中文品名": "因諾-立帕人類白血球抗原擴增試劑組-DRB位點分析",
    "英文品名": "INNO-LiPA HLA-DRB decorder Amplification",
    "效能": "本產品供體外使用，用於擴增人類白血球抗原(HLA)的等位基因DRB1、DRB3、DRB4和DRB5位置上的第二外顯子核酸。該反應是透過聚合酶連鎖反應(PCR)的方式進行。",
    "醫器規格": "80341。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B0001人類白血球抗原分型盤",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "1401804200  台富製藥股份有限公司",
    "申請商地址": "桃園市大園區和平西路一段391號",
    "主製造廠": [
        {
            "製造廠名稱": "MBE0826000  FUJIREBIO EUROPE N.V.",
            "製造廠廠址": "TECHNOLOGIEPARK 6 B-9052 GENT, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560275350001-104-08-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027535&Seq=001&Type=9"
        },
        {
            "title": "560275350002-104-08-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027535&Seq=001&Type=8"
        }
    ]
}